Benzinga | Apr 8, 2021 08:12AM EDT

JP Morgan Maintains Overweight on United Therapeutics, Raises Price Target to $212

JP Morgan analyst Jessica Fye maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and raises the price target from $185 to $212.